EMD

Across TCGA pan-cancer cohorts, EMD Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated EMD data layer compared with 27 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher EMD Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EMD expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

STAD, BLCA, and UCEC are the cancer types where EMD Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.184	0.730	.001	33	view →
BLCA	DFS	Median	All	0.179	0.625	.029	12	view →
UCEC	DFS	Median	All	1.000	0.634	.020	10	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

EMD–STAD (OS)

Open the STAD breakdown →